Oral Health Management of Patients Prescribed Bisphosphonates
Published April 2011
About this guidance
There is an increased risk of oral health complications for patients prescribed bisphosphonate drugs (Bisphosphonate-related Osteonecrosis of the Jaw). This guidance provides clear and practical advice for dentists in primary care on how to provide care for patients prescribed these drugs. The guidance is also of relevance to prescribers and dispensers of bisphosphonates and to patients.
The guidance has been developed by a Guidance Development Group comprising professionals from a range of relevant healthcare disciplines and a patient representative, assisted by our Programme Development Team. A rapid process was adopted to develop this guidance. A draft was made available for consultation for a four week period in October 2010. All responses received were considered by the Guidance Development Group and the guidance was revised accordingly before finalising for publication. Click here for more information on the SDCEP guidance development process.
Guidance Development Group
|David Wray (Chair)||Professor of Oral Medicine, University of Glasgow Dental School|
|David Barlow||Head of the School of Medicine & Professor of Reproductive Medicine, University of Glasgow|
|Alex Crichton||Consultant in Oral Medicine, University of Glasgow Dental Hospital and School|
|Helen Divennie||Specialist Practitioner (Medically Compromised and Oral Surgery), Inverness Dental Centre|
|Elizabeth Foster||Patient Representative|
|Douglas Kennedy||Consultant in Oral & Maxillofacial Surgery, NHS Tayside|
|Pamela Kidd||General Dental Practitioner, Blairgowrie|
|Pauline Lockhart||Clinical Lecturer in Primary Care, University of Dundee; General Practitioner, Dundee|
|Nick Malden||Consultant in Oral Surgery, Edinburgh Dental Institute|
|Avril Neilson||Consultant in Oral Surgery, Dundee Dental Hospital and School|
|Sharon Pfleger||Consultant in Pharmaceutical Public Health, NHS Highland|
|Ross Reid||Associate Advisor, NHS Education for Scotland; General Practittioner, Perth|
|Ario Santini||General Dental Practitioner, West Lothian; Professor, Belgrade University; Chair, FGDP(UK) Research Committee|
SDCEP acknowledges the important contribution of all those who commented during the consultation stage.
Review and updating
This guidance is currently under review.